Pharma Journalist 8962 posts 0 comments

Noramco, a leader in controlled substances and cannabinoids, is adding commercial-scale capacity of dronabinol (THC) at its Athens, Georgia, United States facility. The expansion comes…
Read More...

Neurocrine Biosciences and Jnana Therapeutics announced that they have entered into a research collaboration aimed at discovering novel small molecule therapeutics for multiple targets…
Read More...

Shanghai UniCAR-Therapy Bio-Medicine Technology Co. chose Terumo BCT and its cell expansion devices to automate its cell therapy manufacturing process for chimeric antigen receptor…
Read More...

Wave Life Sciences Ltd. announced plans to design and advance stereopure oligonucleotide therapeutics for the potential treatment of rare, inherited eye diseases. Wave’s research in…
Read More...

Quantitative analysis methods within the PFS and Injectables space at Pre-Filled Syringes 2019 SMi Group will welcome the expertise of Alexander Zuern, Device Testing Manager, from…
Read More...

Novartis announced that both the US Food and Drug Administration (FDA) and European Medicines Agency (EMA) have accepted the company's New Drug Application (NDA) and Marketing…
Read More...

Sarepta Therapeutics announced that it has entered into a long-term strategic manufacturing partnership with Paragon Bioservices (Paragon), which will provide Sarepta access to…
Read More...

Novan announced that the Company has expanded its partnership with Sato Pharmaceutical, a Japanese company with a prescription pharmaceutical business specializing in dermatology, to…
Read More...

Amicus Therapeutics announced a major collaboration with the Gene Therapy Program in the Perelman School of Medicine at the University of Pennsylvania (Penn) to pursue research and…
Read More...

Roche announced that the US Food and Drug Administration (FDA) has approved Hemlibra (emicizumab-kxwh) for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in…
Read More...